The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders.
Milica Medic StojanoskaNatasa MilosevicNatasa MilicLudovico Montebianco AbenavoliPublished in: Endocrine (2016)
The prevalence of obesity and type 2 diabetes mellitus epidemics presents a great health problem worldwide. Beside the changes in diet and decreased physical activity, there is growing interest in endocrine disrupting chemicals that may have effects on these conditions. Among them, the role of certain phthalates and bisphenol A is confirmed. We have summarized the existing literature on this issue including cross-sectional, follow up epidemiological studies and in vivo and in vitro studies. Most data support the effects of bisphenol A and some phthalates, such as di-2-ethyl-hexyl phthalate, diethyl phthalate, dibuthyl phthalate, dimethyl phthalate, dibenzyl phthalate, diisononyl phthalate and others on the development obesity and type 2 diabetes mellitus. These endocrine disrupting chemicals interfere with different cell signaling pathways involved in weight and glucose homeostasis. Since the data are rather inconsistent, there is a need for new, well-designed prospective studies.
Keyphrases
- weight loss
- physical activity
- metabolic syndrome
- insulin resistance
- weight gain
- type diabetes
- high fat diet induced
- cross sectional
- body mass index
- glycemic control
- healthcare
- case control
- signaling pathway
- systematic review
- stem cells
- mental health
- single cell
- risk factors
- blood glucose
- cardiovascular disease
- escherichia coli
- oxidative stress
- risk assessment
- bone marrow
- climate change
- cardiovascular risk factors
- machine learning
- data analysis
- cystic fibrosis
- ionic liquid
- blood pressure
- biofilm formation
- infectious diseases